For people taking weight loss medications like Wegovy and Mounjaro, feeling less hungry can be a welcome change. But when eating less becomes the norm, it may be easier to miss out on important nutrients without realizing it.
A new study published in BMJ Nutrition, Prevention & Health found that some people taking these medications weren't getting enough fiber, vitamin D and other essential nutrients, even though most were consuming adequate protein. The findings suggest that paying attention to protein alone may not be enough to maintain good nutrition during weight loss.
Researchers examined the eating habits of 14 adults in England who were taking medications that suppress appetite. Participants kept track of what they ate and discussed how the medications had changed their relationship with food.
Some were eating surprisingly little. The group's typical daily intake was approximately 1,230 calories, and three participants reported eating fewer than 800 calories a day. Several hadn't realized just how little they were consuming until they recorded their meals.
The researchers also found that 12 of the 14 participants weren't getting even two-thirds of the recommended amount of fiber, while 11 fell below that threshold for vitamin D. Half had similarly low iron intake.
Protein was the exception. Nearly everyone was getting a reasonable amount based on the study's dietary benchmarks, even as their intake of other nutrients fell short.
That's an important distinction because protein has become a major focus of nutrition advice for people using GLP-1 medications, particularly when it comes to maintaining muscle during weight loss. But protein is only one part of a healthy diet. Fiber supports digestive health, while vitamins and minerals play essential roles throughout the body.
The findings add to existing recommendations that nutrition and physical activity remain important parts of GLP-1 treatment.
For some participants, the challenge wasn't necessarily making poor food choices. They simply weren't eating enough overall. Several described skipping meals or eating much smaller portions because they rarely felt hungry. Even people who cooked at home and made an effort to eat healthy foods sometimes fell short on nutrients.
The medications also brought a mix of benefits and challenges. Participants described fewer food cravings, less preoccupation with eating and improvements in their ability to enjoy everyday activities. Others struggled with nausea, reduced enjoyment of food or concerns about regaining weight if they stopped treatment.
Many also said they received little nutritional guidance or ongoing support from their health care providers. Some relied on online communities for advice about side effects and eating habits.
The researchers cautioned that the study was very small and offers only an early look at a potentially important issue. Most participants recorded their diets for just two days, and the researchers didn't know what they typically ate before starting medication. The study also measured nutrient intake rather than confirming deficiencies through medical testing.
That means the findings don't establish that GLP-1 medications cause nutrient deficiencies or show how common these nutritional gaps might be among people taking them.
Still, the results highlight a practical concern: When appetite decreases substantially, people may need additional guidance to make sure they're getting enough nourishment. A health care professional or registered dietitian can help assess eating habits and identify potential nutritional gaps.
As broader obesity treatment guidance has emphasized, managing weight involves more than medication alone. Paying attention to the overall quality and adequacy of what people eat remains an important part of supporting their health.
The researchers did not report any specific grant funding or competing interests. They acknowledged academic support from the NNEdPro Global Institute for Food, Nutrition and Health, including assistance with publication fees.
